Trial Profile
Pilot study of WT1 peptide vaccine therapy for chemorefractory advanced pancreatic cancer.
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 06 Jan 2011
Price :
$35
*
At a glance
- Drugs INNO 305 (Primary)
- Indications Pancreatic cancer
- Focus Adverse reactions; Pharmacodynamics; Therapeutic Use
- Acronyms PDAC-WT1
- 06 Jan 2011 Status changed from recruiting to completed as reported by University Hospital Medical Information Network - Japan.
- 22 Dec 2009 Status changed from not yet recruiting to recruiting as reported by University Hospital Medical Information Network - Japan.
- 22 Dec 2009 Actual initiation date (Jan 2009) added as reported by University Hospital Medical Information Network - Japan.